Literature DB >> 10493989

MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter.

I Ruschenburg1, A Kubitz, T Schlott, M Korabiowska, M Droese.   

Abstract

Differentiation of the papillary variant of papillary thyroid carcinoma (PTC) from papillary hyperplasia in nodular goiter may be difficult in fine-needle aspiration biopsy (FNAB) by means of morphology alone. To improve cytodiagnostic accuracy the occurrence of MAGE-1, GAGE-1/-2 gene expression was analyzed by means of RT-PCR. The genes investigated are recognized by autologous T lymphocytes and are expressed in carcinomas of various sites e.g. lung, ovary, colon but not in non-neoplastic tissue except testis. Routinely obtained smears with cytologic diagnosis of PTC confirmed by histology (n=20) and diagnosis of nodular goiter (n=10) were investigated. The MAGE-1, GAGE-1/-2 PCR products were found in 6/20 of the carcinomas but in none of the benign lesions. To identify PCR products automatic gene-sequencing in all positive cases was performed. The data indicate that MAGE-1, GAGE-1/-2 gene expression may give additional information to delineate PTC from papillary hyperplasia in FNAB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493989     DOI: 10.3892/ijmm.4.4.445

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Configuration and rearrangement of the human GAGE gene clusters.

Authors:  Michael W Killen; Tiffany L Taylor; Dawn M Stults; Weidong Jin; Lisa L Wang; Jeffrey A Moscow; Andrew J Pierce
Journal:  Am J Transl Res       Date:  2011-05-08       Impact factor: 4.060

2.  A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.

Authors:  Viswanath Gunda; Dennie T Frederick; Maria J Bernasconi; Jennifer A Wargo; Sareh Parangi
Journal:  Thyroid       Date:  2014-06-30       Impact factor: 6.568

3.  Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.

Authors:  Viswanath Gunda; Alexandria P Cogdill; Maria J Bernasconi; Jennifer A Wargo; Sareh Parangi
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

4.  Advances in cellular therapy for the treatment of thyroid cancer.

Authors:  Claudia Papewalis; Margret Ehlers; Matthias Schott
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

5.  Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.

Authors:  M F Gjerstorff; L E Johansen; O Nielsen; K Kock; H J Ditzel
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

6.  CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.

Authors:  Mariana Bonjiorno Martins; Marjory Alana Marcello; Fernando de Assis Batista; Lucas Leite Cunha; Elaine Cristina Morari; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  J Immunol Res       Date:  2014-11-04       Impact factor: 4.818

7.  An epigenome-wide association study of sex-specific chronological ageing.

Authors:  Daniel L McCartney; Futao Zhang; Robert F Hillary; Qian Zhang; Anna J Stevenson; Rosie M Walker; Mairead L Bermingham; Thibaud Boutin; Stewart W Morris; Archie Campbell; Alison D Murray; Heather C Whalley; David J Porteous; Caroline Hayward; Kathryn L Evans; Tamir Chandra; Ian J Deary; Andrew M McIntosh; Jian Yang; Peter M Visscher; Allan F McRae; Riccardo E Marioni
Journal:  Genome Med       Date:  2019-12-31       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.